Is there in truth no beauty?
June 13, 2018

truePTS, an automated trade processing platform for derivatives, reports from New York that it has processed its first buy-side trades, with JP Morgan and Citadel, as demand grows across the industry for a fully-integrated allocation and validation platform.

With electronic execution becoming standard, the need for physical confirmation has been replaced by demand for automated, real-time matching and front-to-back trade flows, says true PTS. It adds that its 'no-touch' processing environment delivers these features at greater speed and cost effectiveness than traditional systems, automating complex instruments such as swaptions.

"This is an exciting development in the post-trade industry," said Kieran Hanrahan, Global Head of Markets Middle Office at JP Morgan. "Buy-side firms' participation will be critical to the scalability of the truePTS platform."

"In recent years, derivatives trading has migrated to electronic venues which has significantly improved execution workflow, but post-trade processing for many of these instruments still relies on legacy technology resulting in inefficiencies downstream," said Dan Dufresne, Global Treasurer at Citadel. He agrees that the truePTS offering, will improve post-trade efficiency, decrease costs, and reduce operational risk.





This site, like many others, uses small files called cookies to customize your experience. Cookies appear to be blocked on this browser. Please consider allowing cookies so that you can enjoy more content across fundservices.net.

How do I enable cookies in my browser?

Internet Explorer
1. Click the Tools button (or press ALT and T on the keyboard), and then click Internet Options.
2. Click the Privacy tab
3. Move the slider away from 'Block all cookies' to a setting you're comfortable with.

Firefox
1. At the top of the Firefox window, click on the Tools menu and select Options...
2. Select the Privacy panel.
3. Set Firefox will: to Use custom settings for history.
4. Make sure Accept cookies from sites is selected.

Safari Browser
1. Click Safari icon in Menu Bar
2. Click Preferences (gear icon)
3. Click Security icon
4. Accept cookies: select Radio button "only from sites I visit"

Chrome
1. Click the menu icon to the right of the address bar (looks like 3 lines)
2. Click Settings
3. Click the "Show advanced settings" tab at the bottom
4. Click the "Content settings..." button in the Privacy section
5. At the top under Cookies make sure it is set to "Allow local data to be set (recommended)"

Opera
1. Click the red O button in the upper left hand corner
2. Select Settings -> Preferences
3. Select the Advanced Tab
4. Select Cookies in the list on the left side
5. Set it to "Accept cookies" or "Accept cookies only from the sites I visit"
6. Click OK

truePTS, an automated trade processing platform for derivatives, reports from New York that it has processed its first buy-side trades, with JP Morgan and Citadel, as demand grows across the industry for a fully-integrated allocation and validation platform.

With electronic execution becoming standard, the need for physical confirmation has been replaced by demand for automated, real-time matching and front-to-back trade flows, says true PTS. It adds that its 'no-touch' processing environment delivers these features at greater speed and cost effectiveness than traditional systems, automating complex instruments such as swaptions.

"This is an exciting development in the post-trade industry," said Kieran Hanrahan, Global Head of Markets Middle Office at JP Morgan. "Buy-side firms' participation will be critical to the scalability of the truePTS platform."

"In recent years, derivatives trading has migrated to electronic venues which has significantly improved execution workflow, but post-trade processing for many of these instruments still relies on legacy technology resulting in inefficiencies downstream," said Dan Dufresne, Global Treasurer at Citadel. He agrees that the truePTS offering, will improve post-trade efficiency, decrease costs, and reduce operational risk.



Free subscription - selected news and optional newsletter
Premium subscription
  • All latest news
  • Latest special reports
  • Your choice of newsletter timing and topics
Full-access magazine subscription
  • 7-year archive of news
  • All past special reports
  • Newsletter with your choice of timing and topics
  • Access to more content across the site